Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Roy Lobb"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/84a97198f4cf4631a78e8d0a5b332b21
Publikováno v:
Cells, Vol 12, Iss 2, p 248 (2023)
The efficacy of CD19-specific CAR T cells in the treatment of leukemia/lymphoma relies, at least in part, on the unique properties of the particular CAR and the presence of healthy B cells that enhance the target cell lysis and cytokine secretion thr
Externí odkaz:
https://doaj.org/article/01fa912584b2484ab308bc29215d691d
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/29ca25875ed04214bdf8dfc827f09f7d
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Ashfaq Ahmed, Roy Lobb, Yelena Botinnikova, Ko-Chung Lin, Alan J. Gill, M. W. Sielczak, William M. Abraham, Diane R. Leone, Isabel T. Lauredo, Steven P. Adams, Blake Pepinsky
Publikováno v:
American journal of respiratory and critical care medicine. 162(2 Pt 1)
The leukocyte integrin very late antigen-4 (alpha(4)beta(1), CD49d/CD29) is an adhesion receptor that plays an important role in allergic inflammation and contributes to antigen-induced late responses (LAR) and airway hyperresponsiveness (AHR). In th
Autor:
Hombach, Andreas A.1,2 (AUTHOR) andreas.hombach@uk-koeln.de, Ambrose, Christine3 (AUTHOR), Lobb, Roy3 (AUTHOR), Rennert, Paul3 (AUTHOR), Abken, Hinrich4 (AUTHOR)
Publikováno v:
Cells (2073-4409). Jan2023, Vol. 12 Issue 2, p248. 12p.
Autor:
Chigaev, Alexandre1,2,3 achigaev@salud.unm.edu, Smagley, Yelena1,2,3 ysmagley@salud.unm.edu, Sklar, Larry A.1,2,3 lsklar@salud.unm.edu
Publikováno v:
BMC Immunology. 2014, Vol. 15 Issue 1, p2-32. 31p.
Publikováno v:
BMC Immunology. 2011, Vol. 12 Issue 1, p28-40. 13p.
Autor:
Aleta Biotherapeutics
Publikováno v:
Business Wire (English). 12/02/2019.